Human monoclonal antibodies neutralizing varicella-zoster virus. 1985

S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin

Hybridomas secreting human monoclonal antibodies to varicella-zoster virus were produced by fusing B cells of a patient recovering from acute varicella infection with a human-mouse cell line. Two hybrid lines have continued to secrete IgG1, one with kappa and the other with lambda chains, for at least 12 months. Each antibody neutralizes virus infectivity between 1-5 micrograms of partially purified immunoglobulin/ml, each shows a different pattern of immunofluorescent staining of virus-infected cells, and one identifies three viral proteins with molecular weights of 60,000, 95,000, and 97,000.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus

Related Publications

S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
March 1987, European journal of immunology,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
January 1997, Archives of virology,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
October 1991, Journal of virology,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
June 2007, Journal of medical virology,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
January 1982, Archives of virology,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
April 1983, Infection and immunity,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
September 1975, Infection and immunity,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
January 2009, Journal of immunoassay & immunochemistry,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
April 2000, Hybridoma,
S K Foung, and S Perkins, and C Koropchak, and D M Fishwild, and A E Wittek, and E G Engleman, and F C Grumet, and A M Arvin
December 2004, The Journal of general virology,
Copied contents to your clipboard!